Pfizer says high dose Lipitor cuts bypass surgery risk
pharmiweb.co.uk     May 23, 2008            

New York Pfizer Inc, has announced that Lipitor (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 per cent in patients with heart disease who had previous coronary bypass surgery compared with patients taking the... [read full story]                    


View all news articles about*:
Aid Care Cholesterol Diet Drugs General Health Hospital Hospitals Medicines Patients Pfizer Pharmaceuticals Remedies Surgery
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

                   

Cholesterol study sinks drug stocks

app.com     7 hrs ago   1 related          

Shares of Readington-based Merck & Co. and Kenilworth-based Schering-Plough Corp. fell to record lows Monday, as analysts warned new clinical data would cause sales of their blockbuster cholesterol drug Vytorin to fall...                    

comments

Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ranbaxy Generic Product before...

yahoo.com     23 hrs ago   2 related          

NEW YORK----Pfizer Inc said today that the Eastern Division of the High Court in Copenhagen, Denmark has ruled in the company's favor in challenges to two of its patents covering atorvastatin, the active ingredient in...                    

comments

Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ranbaxy Generic Product before...

businesswire.com     23 hrs ago   3 related          

NEW YORK-- --Pfizer Inc said today that the Eastern Division of the High Court in Copenhagen, Denmark has ruled in the company’s favor in challenges to two of its patents covering atorvastatin, the active ingredient in...                    

comments

                   

The New York Stem Cell Foundation Announces Third Annual Translational Stem Cell Research Conference

medicalnewstoday.com     yesterday   3 related          

The leading figures in stem cell science will present the latest and most exciting breakthroughs in this revolutionary field of research at NYSCF's Third Annual Translational Stem Cell Research Conference, October 14-15...                    

comments